Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis.
In the breakdown of fluid phase C3 in plasma, the process of conversion of iC3b to C3c and 'C3d' has not been elucidated. Using fluorescent labeled iC3b as a substrate, urokinase (UK) treated but not normal plasma was found to exhibit effective 'C3d' production. To address the relationship between the fibrinolytic activity specific for UK-activated plasma and this 'C3d' production, an assay system was developed that permitted the simultaneous determination of both activities. This method indicated that 'C3d' generation paralleled that of plasmin-dependent fibrinogen degradation. A Km of iC3b for plasmin was 3.0 X 10(-6) mol/l which is similar to the Km of fibrinogen. Plasmin cleavage of iC3b gave rise to C3d1 (Mr 42,000) and C3d2 (Mr 28,000). Purified plasmin C3d1 showed the same Mr and pI as C3d,g prepared from iC3b, by H and I. C3d2 was derived from C3d1. From these in vitro experiments with urokinase-treated plasma, we conclude that in parallel with fibrinolysis efficient cleavage of fluid phase iC3b to C3c + C3d,g and C3d occurs and we hypothesize that this is one mechanism for the generation of C3d in vivo.
D003176:Complement C3 / Q000096:biosynthesis*; D003179:Complement C3b / Q000096:biosynthesis* / Q000378:metabolism; D015933:Complement C3d; D005341:Fibrinolysin / Q000378:metabolism; D005342:Fibrinolysis; D006801:Humans; D066298:In Vitro Techniques; D007526:Isoelectric Point; D007700:Kinetics; D008970:Molecular Weight; D010446:Peptide Fragments / Q000096:biosynthesis*; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
D003176:Complement C3; D010446:Peptide Fragments; C045477:complement C3d,g; D003179:Complement C3b; D015933:Complement C3d; D005341:Fibrinolysin; D014568:Urokinase-Type Plasminogen Activator